Concordance Between a Mohs Micrographic Surgeon and Dermatopathologist on Margin Status for Melanoma In Situ and the Role of Immunohistochemical Stains.
Arianna F Yanes, Amina Bougrine, Adriano Piris, Emily S Ruiz, Abigail Waldman
{"title":"Concordance Between a Mohs Micrographic Surgeon and Dermatopathologist on Margin Status for Melanoma In Situ and the Role of Immunohistochemical Stains.","authors":"Arianna F Yanes, Amina Bougrine, Adriano Piris, Emily S Ruiz, Abigail Waldman","doi":"10.1097/DSS.0000000000004673","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Few studies have examined the concordance between Mohs surgeons and dermatopathologists' interpretation of margin status during Mohs micrographic surgery (MMS) for melanoma in situ (MIS).</p><p><strong>Objective: </strong>The objectives of this study were to determine the concordance between a Mohs surgeon and dermatopathologist on margin status for MIS and to analyze the role of immunohistochemical stains during Mohs surgery.</p><p><strong>Materials and methods: </strong>This was a prospective study at 1 academic center of patients undergoing Mohs surgery for MIS. The Mohs surgeon and dermatopathologist independently examined the margins and completed surveys on the usefulness of H&E and immunohistochemical stains in each case. Six-year follow-up data on tumor recurrence and metastasis were collected.</p><p><strong>Results: </strong>The surgeon and dermatopathologist agreed on margin status in 95% of cases (95% confidence interval: 0.84-0.99). The dermatopathologist found H&E alone to be the most useful stain for the first stage of MMS, while the Mohs surgeon found the combination of H&E and SOX10 most useful. This study is limited by the use of only 2 physicians.</p><p><strong>Conclusion: </strong>There was a high concordance between the Mohs surgeon and dermatopathologist on MIS margin status. Immunohistochemical stains were more useful for the Mohs surgeon.</p>","PeriodicalId":11289,"journal":{"name":"Dermatologic Surgery","volume":" ","pages":""},"PeriodicalIF":2.5000,"publicationDate":"2025-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Dermatologic Surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/DSS.0000000000004673","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Few studies have examined the concordance between Mohs surgeons and dermatopathologists' interpretation of margin status during Mohs micrographic surgery (MMS) for melanoma in situ (MIS).
Objective: The objectives of this study were to determine the concordance between a Mohs surgeon and dermatopathologist on margin status for MIS and to analyze the role of immunohistochemical stains during Mohs surgery.
Materials and methods: This was a prospective study at 1 academic center of patients undergoing Mohs surgery for MIS. The Mohs surgeon and dermatopathologist independently examined the margins and completed surveys on the usefulness of H&E and immunohistochemical stains in each case. Six-year follow-up data on tumor recurrence and metastasis were collected.
Results: The surgeon and dermatopathologist agreed on margin status in 95% of cases (95% confidence interval: 0.84-0.99). The dermatopathologist found H&E alone to be the most useful stain for the first stage of MMS, while the Mohs surgeon found the combination of H&E and SOX10 most useful. This study is limited by the use of only 2 physicians.
Conclusion: There was a high concordance between the Mohs surgeon and dermatopathologist on MIS margin status. Immunohistochemical stains were more useful for the Mohs surgeon.
期刊介绍:
Exclusively devoted to dermatologic surgery, the Dermatologic Surgery journal publishes the most clinically comprehensive and up-to-date information in its field. This unique monthly journal provides today’s most expansive and in-depth coverage of cosmetic and reconstructive skin surgery and skin cancer through peer-reviewed original articles, extensive illustrations, case reports, ongoing features, literature reviews and correspondence. The journal provides information on the latest scientific information for all types of dermatologic surgery including:
-Ambulatory phlebectomy-
Blepharoplasty-
Body contouring-
Chemical peels-
Cryosurgery-
Curettage and desiccation-
Dermabrasion-
Excision and closure-
Flap Surgery-
Grafting-
Hair restoration surgery-
Injectable neuromodulators-
Laser surgery-
Liposuction-
Microdermabrasion-
Microlipoinjection-
Micropigmentation-
Mohs micrographic surgery-
Nail surgery-
Phlebology-
Sclerotherapy-
Skin cancer surgery-
Skin resurfacing-
Soft-tissue fillers.
Dermatologists, dermatologic surgeons, plastic surgeons, oculoplastic surgeons and facial plastic surgeons consider this a must-read publication for anyone in the field.